Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROLONG: Ebopiprant Added to Atosiban in Preterm Labor
NCT03369262Phase 2Unknown
- Sponsor
- ObsEva SA
- Start
- Jan 2018
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of ebopiprant in Preterm labor (PTL), sponsored by ObsEva SA. Status: unknown.
02
Drugs
ebopiprant
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on NCT03369262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03369262.